Two Pharma Giants Successfully Navigate a Challenging Climate

In May, the Trump administration released a blueprint for its plans to reduce the price of prescription drugs. The first sentence was “A BURDEN ON THE AMERICAN PEOPLE: Drug prices are being driven up unfairly, taking a toll on the American people.”

The plan seeks to increase competition in the market for prescription drugs and was seen as a shot over the bow of pharmaceutical manufacturers.